GC3107

BIOLOGICAL2 trials

Sponsors

Green Cross Corporation

Conditions

BCG Vaccination ReactionTuberculosis

Phase 1

Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults

Green Cross CorporationTuberculosis

Start: 2017-12-14End: 2018-03-31Target: 20Updated: 2017-12-18

Phase 3

A Study of GC3107(BCG Vaccine) in Healthy Infants

CompletedNCT03947138

Green Cross CorporationBCG Vaccination Reaction, Tuberculosis

Start: 2019-08-06End: 2022-09-06Updated: 2022-11-02